Oral contraceptives and the risk of breast cancer

New England Journal of Medicine

Volumn 346, Issue 26, 2002, Pages 2025-2032

  Marchbanks, Polly A ^a   McDonald, Jill A ^a   Wilson, Hoyt G ^a   Folger, Suzanne G ^a   Mandel, Michele G ^a   Daling, Janet R ^b   Bernstein, Leslie ^c   Malone, Kathleen E ^b   Ursin, Giske ^c   Strom, Brian L ^d   Norman, Sandra A ^d   Wingo, Phyllis A ^f   Burkman, Ronald T ^g   Berlin, Jesse A ^d   Simon, Michael S ^e   Spirtas, Robert ^h   Weiss, Linda K ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

^g Baystate Med Cent   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; DRUG EFFECT; FAMILY HISTORY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; RISK FACTORS;

EID: 0037182768     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa013202     Document Type: Article

References (25)

1. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
2. Breast cancer and hormonal contraceptives: Further results
3. The NICHD Women's Contraceptive and Reproductive Experiences Study: Methods and operational results
4. The evaluation of the data collection process for a multicenter, population-based, case-control design
5. Validity of pharmacoepidemiology drug and diagnosis data
6. The pill: Combined oral contraceptives
7. On the need for the rare disease assumption in case-control studies
8. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
9. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
10. Should women with a family history of breast cancer avoid use of oral contraceptives?
11. Cancer incidence and mortality, 1973-1995: A report card for the U.S.
12. Differences in breast cancer prognosis among African-American and Caucasian women
13. Cancer statistics, 2000
14. Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study
15. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States
16. A comparison of estrogen and progesterone receptors in black and white breast cancer patients
17. Histological characteristics of breast carcinoma in blacks and whites
18. Trends in contraceptive use in the United States: 1982-1995
19. Age-specific differences in the relationship between oral contraceptive use and breast cancer
20. The ability of women to recall their oral contraceptive histories